Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
Bethany Brown, Senior Director of Transfusion Innovation and Product Development at American Red Cross, shared on LinkedIn:
”It was a pleasure working together with Rebecca Cardigan, Jose A. Cancelas, Tamir Kanias, Thomas Klei, and the BEST Collaborative on this Commentary “Clinical evaluation of novel blood collection and storage bags containing alternative plasticizers to DEHP: Recommendations from the BEST Collaborative”.
Here, we developed recommendations related to the in vivo data required in relation to replacing DEHP in blood bags to support conversations and alignment of bag manufacturers, regulators, and blood centers in the context of changes in EU regulations.”
Read the full article in Transfusion.
Article: Clinical evaluation of novel blood collection and storage bags containing alternative plasticizers to DEHP: Recommendations from the BEST collaborative
Authors: Bethany Brown, Thomas R. L. Klei, Tamir Kanias, Dirk de Korte, Jose A. Cancelas, Rebecca Cardigan
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 11, 2026, 18:27Cesar Garrido and Lackram Bodoe Are Advancing WFH Partnerships in Trinidad and Tobago
-
Mar 11, 2026, 18:14Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
-
Mar 11, 2026, 17:23Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
-
Mar 11, 2026, 17:12Shubham Misra: Proteomic Biomarkers for Acute Stroke Subtype Classification
-
Mar 11, 2026, 16:55Melanie Daniel: Modeling High-Purity von Willebrand Factor for Individualized Dosing in Surgery
-
Mar 11, 2026, 15:46Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
-
Mar 11, 2026, 15:37Sonia Muliyil: The Greatest Benefit is The Wellbeing and Sustenance of Half The World’s Population
-
Mar 11, 2026, 15:34Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
-
Mar 11, 2026, 15:34Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening